. LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer. J Urol 2023 May 2:101097JU0000000000003518. doi: 10.1097/JU.0000000000003518.
PMID: 37119051